GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Elbit Medical Technologies Ltd (XTAE:EMTC-M) » Definitions » EBIT

Elbit Medical Technologies (XTAE:EMTC-M) EBIT : ₪-53.44 Mil (TTM As of Jun. 2024)


View and export this data going back to 1993. Start your Free Trial

What is Elbit Medical Technologies EBIT?

Elbit Medical Technologies's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was ₪1.58 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was ₪-53.44 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Elbit Medical Technologies's annualized ROC % for the quarter that ended in Jun. 2024 was -8.40%. Elbit Medical Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was %.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Elbit Medical Technologies's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -576.24%.


Elbit Medical Technologies EBIT Historical Data

The historical data trend for Elbit Medical Technologies's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elbit Medical Technologies EBIT Chart

Elbit Medical Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -67.27 456.52 -47.80 -18.42 -64.13

Elbit Medical Technologies Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.21 -17.21 -9.12 -55.01 1.58

Competitive Comparison of Elbit Medical Technologies's EBIT

For the Medical Devices subindustry, Elbit Medical Technologies's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elbit Medical Technologies's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Elbit Medical Technologies's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Elbit Medical Technologies's EV-to-EBIT falls into.



Elbit Medical Technologies EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₪-53.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elbit Medical Technologies  (XTAE:EMTC-M) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Elbit Medical Technologies's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-1.838 * ( 1 - 0% )/( (20.828 + 22.912)/ 2 )
=-1.838/21.87
=-8.40 %

where

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Elbit Medical Technologies's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2024 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Dec. 2023  Q: Jun. 2024
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=3.158/( ( (0 + max(-0.677, 0)) + (0 + max(-0.512, 0)) )/ 2 )
=3.158/( ( 0 + 0 )/ 2 )
=3.158/0
= %

where Working Capital is:

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.032 + 0 + 0.0010000000000003) - (0.627 + 0 + 0.083)
=-0.677

Working Capital(Q: Jun. 2024 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0.068 + 0 + 8.8817841970013E-16) - (0.58 + 0 + 0)
=-0.512

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Elbit Medical Technologies's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2024 )
=-53.435/9.273
=-576.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elbit Medical Technologies EBIT Related Terms

Thank you for viewing the detailed overview of Elbit Medical Technologies's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Elbit Medical Technologies Business Description

Traded in Other Exchanges
Address
Shimshon Street 3, Petah Tikva, ISR, 4900102
Elbit Medical Technologies Ltd is a holding company in the biomedical field. It has investments in two subsidiaries namely, InSightec & Gamida Cell. Through these divisions it develops & markets magnetic resonance imaging guided ultrasound equipment & develops stem cell therapeutics & future regenerative cell-based medicines.

Elbit Medical Technologies Headlines

No Headlines